[1]
Bryg, S. et al. 2026. Belantamab Mafodotin: Ocular Toxicity and Comparative Evaluation across Antibody–Drug Conjugates. Quality in Sport. 77, (Oct. 2026), 76212. DOI:https://doi.org/10.12775/QS.2026.77.76212.